1. Analysis of MRN-dependent and -independent topoisomerase removal mechanisms: implications for resistance against camptothecin and etoposide derivatives

   Hartsuiker, E. (PI)

   1/09/10 → 31/08/16

   Project: Research

2. Exploiting synthetic lethality for cancer treatment: improving the activity and specificity of novel MRE11 inhibitors

   Hartsuiker, E. (PI)

   1/10/25 → 15/10/28

   Project: Research

3. Funding for equipment

   Hartsuiker, E. (PI)

   1/01/15 → 1/08/24

   Project: Research

4. Genome-wide analysis of topoisomerase removal after camptothecin treatment

   Hartsuiker, E. (PI)

   1/10/11 → 31/12/14

   Project: Research

5. Genome-wide analysis of topoisomerase removal pathways

   Hartsuiker, E. (PI)

   1/09/15 → 1/08/19

   Project: Research

6. Identification and analysis of DNA repair mechanisms that contribute to resistance against nucleoside analogues

   Hartsuiker, E. (PI)

   1/10/10 → 30/09/14

   Project: Research

7. KESS II MRes with NWCR - BUK2E091

   Hartsuiker, E. (PI)

   1/10/22 → 1/08/24

   Project: Research

8. KESS II MRes with North West Cancer Research BUK2222

   Hartsuiker, E. (PI)

   1/01/21 → 31/01/22

   Project: Research

9. KESS II MRes with North West Cancer Research BUK2224

   Hartsuiker, E. (PI)

   1/01/21 → 1/08/24

   Project: Research

10. KESS II MRes with North West Cancer Research- BUK2175

    Hartsuiker, E. (PI)

    1/10/18 → 1/08/22

    Project: Research